9-Oxo-9H-fluorene-4-carboxylic acid

Catalog No.: 
ACDHPI854
CAS No.: 
6223-83-2
Molecular Formula: 
C14H8O3
Molecular Weight: 
224.21
9-Oxo-9H-fluorene-4-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$91.00In stockInquiry
100g97%$257.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name9-Oxo-9H-fluorene-4-carboxylic acid
IUPAC Name9-oxo-9H-fluorene-4-carboxylic acid
MDL No.MFCD00001145
Molecular FormulaC14H8O3
Molecular Weight224.21
SMILESOC(=O)C1=C2C(=CC=C1)C(=O)C1=CC=CC=C21
InChI KeyAFQYQSWTVCNJQT-UHFFFAOYSA-N
Synonym9-Oxo-9H-fluorene-4-carboxylic acid # | CS-W014225 | FLUORENONE-5-CARBOXYLIC ACID | EINECS 228-311-9 | SR-01000596916 | FLUORENE-4-CARBOXYLIC ACID, 9-OXO- | MFCD00001145 | AKOS001581033 | F0804 | 9-Oxofluorene-4-carboxylic acid | MLS000737111 | SR-0100059
CAS No.6223-83-2
PubChem CID80361

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACDHPI854 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHCSD375 route compound structure diagram
    ACHCSD375482-05-3In Stock
  2. Then
  3. ACDHPI854 route product structure diagram
    ACDHPI8546223-83-2In Stock
Inquiry

2. ACDHPI854 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHCSD375 route compound structure diagram
    ACHCSD375482-05-3In Stock
  2. Plus
  3. ACBFSC511 route compound structure diagram
    ACBFSC51143086-58-4
  4. Then
  5. ACDHPI854 route product structure diagram
    ACDHPI8546223-83-2In Stock
Inquiry

3. ACDHPI854 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDHPI854 route product structure diagram
    ACDHPI8546223-83-2In Stock
Inquiry

Comments (0)